Filter
1586
Filtered Results: 1586
Text search:
assays
Featured
Recommendations
203
New Publications
426
Language
Document type
No document type
898
Guidelines
321
Studies & Reports
183
Manuals
68
Strategic & Response Plan
46
Fact sheets
41
Training Material
14
Situation Updates
8
Resource Platforms
4
Infographics
2
Online Courses
1
Countries / Regions
India
101
Western and Central Europe
46
Global
44
South Africa
32
Germany
26
Eastern Europe
26
Tanzania
24
Africa
23
Latin America and the Carribbean
23
Kenya
22
Nigeria
22
Nepal
21
Brazil
21
Uganda
20
Ethiopia
20
Russia
18
Sierra Leone
17
Syria
17
Malawi
17
Ukraine
16
Liberia
16
Congo, Democratic Republic of
15
Myanmar / Burma
15
Mozambique
14
Zambia
14
Colombia
13
Ghana
13
Rwanda
13
Bangladesh
13
West and Central Africa
11
Middle East and North Africa
10
East and Southern Africa
10
Namibia
10
Haiti
9
Venezuela
9
Philippines
8
South–East Asia Region
8
Argentina
8
Lesotho
7
Senegal
7
Cambodia
7
Asia
7
Central African Republic
7
Burkina Faso
6
Peru
6
Zimbabwe
6
Eastern Europe and Central Asia
6
Indonesia
6
Madagascar
6
Benin
5
Cameroon
5
USA
5
Yemen
5
Angola
5
Mexico
4
El Salvador
4
Chile
4
Bolivia
4
Mali
4
Somalia
4
Ecuador
4
Eswatini/ Swaziland
4
Niger
3
Afghanistan
3
Jordan
3
Saudi Arabia
3
Western Pacific Region
3
Paraguay
3
Lebanon
3
Sri Lanka
3
Sudan
3
Libya
3
Botswana
3
Pakistan
3
Timor Leste/ East Timor
2
China
2
Iran
2
Qatar
2
Guinea
2
Armenia
2
Dominican Republic
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Moldova
2
Egypt
2
Palestine
2
Georgia
2
Chad
2
Bhutan
2
Iraq
2
North Macedonia
1
Tajikistan
1
North Korea
1
Switzerland
1
Turkey
1
Kazakhstan
1
Albania
1
Estonia
1
Congo-Brazzaville
1
Morocco
1
Mongolia
1
Mauritania
1
Guinea-Bissau
1
North America
1
Uruguay
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Romania
1
Honduras
1
South Sudan
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
540
Clinical Guidelines
248
Pharmacy & Technologies
66
Public Health
62
Key Resources
27
Women & Child Health
26
Capacity Building
7
Toolboxes
TB
313
COVID-19
179
HIV
176
NTDs
87
Rapid Response
80
Ebola
49
AMR
32
Refugee
30
Zika
30
Pharmacy
29
Conflict
26
Mental Health
21
NCDs
21
Planetary Health
17
Polio
13
Natural Hazards
10
Caregiver
9
Specific Hazards
8
Cholera
3
Health Financing Toolbox
3
Global Health Education
3
Disability
2
Climate change, increasing population densities, and intensified globalisation in trade, travel and migration are among the most important factors shaping the 21st century. Each impacts upon population health and the risk of infectious disease, particularly those originating at the human-animal-envi...
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
Tuberculosis (TB)
recommended
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
This document offers public health guidance for the prevention and control of COVID-19 in reception centres, and other temporary accommodation facilities, in the context of the mass influx of Ukrainian people into the European Union (EU), the European Economic Area (EEA) and the Republic of Moldova.
Laboratory Biossafety Manual
The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats. Genomic surveillance is part of the broader surveillance and laboratory system, a...
Plan Estratégico
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome c...
Due to the particular Amazonian situation of vectorial transmission based mostly on the wild cycle of Trypanosoma cruzi with diversity of triatomine vectors involved in effective transmission, and the variety of eco-epidemiological situations that facilitate such transmission, the countries of the A...
Este documento presenta modelos de algoritmos que permiten investigar por métodos bacteriológicos a los pacientes para el diagnóstico de tuberculosis (TB), TB asociada al Virus de Inmunodeficiencia Humana (TB-HIV) y TB drogorresistente (TBDR).
Clinical guideline for paediatric care of tuberculosis and TB-HIV co-infection
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Cancer in sub-Saharan Africa
recommended
Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality.
Without rapid interventions, data estimates show a major increase in cancer mo...
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu...
